# Validation Summary Report — TransTrack v1.2.0 (Worked Example)

> ## ⚠ DEMONSTRATION ONLY — NOT A REAL VALIDATION RECORD
>
> "Northshore Regional Transplant Center" is a **fictional** organization.
> All counts, defect numbers, and signatures below are **synthetic**
> demonstration data. See [`README.md`](README.md) for the disclaimer.
> This file's purpose is to model what a populated VSR looks like for a
> real pilot site that will replace the example data with their own.

---

| Field | Value |
|---|---|
| Document ID | TT-VSR-NRTC-2026-001 (example) |
| Software version | **v1.2.0** (build `e1436e2`, commit SHA from `git log -1 main`) |
| Customer organization | **Northshore Regional Transplant Center** *(fictional, demonstration)* |
| Validation period | 2026-05-15 to 2026-06-30 *(example)* |
| Reference Validation Plan | TT-VP-001 v1.0 |
| Author | _Sarah Chen, RN — Validation Lead_ *(role-title placeholder)* |
| Approver | _Marcus Johnson, MS — Quality Assurance Officer_ *(role-title placeholder)* |
| Date approved | 2026-07-02 *(example)* |

## 1. Executive summary

TransTrack v1.2.0 has been validated for production use at Northshore
Regional Transplant Center (the *Center*) in support of pre-transplant
patient coordination. All Mandatory requirements were verified through the
executed IQ, OQ, and PQ protocols (see [`IQ_PROTOCOL_EXAMPLE.md`](IQ_PROTOCOL_EXAMPLE.md),
[`OQ_PROTOCOL_EXAMPLE.md`](OQ_PROTOCOL_EXAMPLE.md), and
[`PQ_PROTOCOL_EXAMPLE.md`](PQ_PROTOCOL_EXAMPLE.md)). Three Severity-3
defects were identified during OQ; all three have a documented mitigation
or are tracked for the v1.3 release with accepted-risk sign-off. No
Severity-1 or Severity-2 defects remain open at sign-off.

The Center is authorized to use TransTrack v1.2.0 in production at its
single transplant-coordination workstation effective 2026-07-02 *(example)*,
under periodic-review obligations defined in `TT-VP-001 §8`.

## 2. Validation activities executed

| Activity | Document | Result | Date | Executor |
|---|---|---|---|---|
| Installation Qualification | TT-IQ-NRTC-001 ([example](IQ_PROTOCOL_EXAMPLE.md)) | **PASS** (12/12) | 2026-05-22 | Center IT (J. Park) |
| Operational Qualification | TT-OQ-NRTC-001 ([example](OQ_PROTOCOL_EXAMPLE.md)) | **PASS with conditions** (38/41 mandatory, 3 deferred to v1.3) | 2026-06-05 | Validation Lead |
| Performance Qualification | TT-PQ-NRTC-001 ([example](PQ_PROTOCOL_EXAMPLE.md)) | **PASS** (12/12) | 2026-06-25 | Validation Lead + 2 coordinators |
| Risk Register review | TT-RISK-001 v1.0 | Reviewed; no deltas | 2026-06-28 | QA Officer |
| Traceability Matrix review | TT-TRACE-NRTC-001 | 100% Mandatory coverage | 2026-06-30 | QA Officer |

## 3. Defects and deviations

| Defect ID | Severity | Description | Resolution | Closed? |
|---|---|---|---|---|
| DEF-001 | 3 | OQ-22 trigger emits a generic SQLite error string when audit_logs UPDATE is attempted under SQLCipher v4.6 (the test still PASSES because the row remains unchanged, but the error message lacks the documented "HIPAA Compliance:" prefix). | Logged for cosmetic fix in v1.3; functional immutability remains intact. **Accepted risk** signed by QA Officer 2026-06-29. | Yes (mitigated) |
| DEF-002 | 3 | OQ-43 (corrupt-DB-restart): the integrity-check failure dialog shows the path in OS-locale form, which on the Center's Windows install displayed forward slashes inverted from the documentation screenshot. Functional behavior identical. | Documentation update in `docs/USER_GUIDE.md` § "Recovery dialogs" scheduled for v1.2.1. | Yes (documentation) |
| DEF-003 | 3 | OQ-69 (ADT^A01 ingest): when an ingested HL7 v2 message contains a free-text `OBX-5` longer than 4 KB, the parser logs a warning to `transtrack.log` but the patient record is created correctly. The Center's HL7 sender does not produce such messages in normal operation. | Logged for the v1.3 input-validation hardening sprint; no Center workflow impacted. | Open (tracked, accepted) |

(No Severity 1 or 2 defects remain open at sign-off.)

## 4. Residual risk acceptance

The Quality Assurance Officer has reviewed the Risk Register
(`docs/compliance/RISK_REGISTER.md`, TT-RISK-001 v1.0) and accepts all
residual risks classified Low or Medium with documented mitigations.

| Risk ID | Residual class | Accepted at the Center (Y/N) | Notes |
|---|---|---|---|
| R-001 (stolen workstation creds) | Med | Y | Mitigated by Center's BitLocker + per-user accounts + 12 h idle timeout. |
| R-002 (compromised admin creds) | Med | Y | TOTP MFA mandatory for the single admin account. |
| R-003 (audit-log tampering) | Low | Y | DB triggers verified by OQ-22. |
| R-004 (unencrypted backup PHI) | Low | Y | Backup verified encrypted by OQ-40 + PQ-09. |
| R-005 (lost SQLCipher key) | Med | Y | Key backed up to Center's offline safe per local SOP `NRTC-SEC-014`. |
| R-006 (priority score misread as allocation) | Low | Y | Verified labels visible by OQ-62 + PQ-12. |
| R-007 (calculator misuse) | Low | Y | "Insufficient data" hard-stop verified by OQ-61. |
| R-008 (HL7 duplicate patients) | Med | Y | MRN+DOB matching verified by PQ-02; admin queue used. |
| R-009 (SIEM PHI leakage) | Low | Y | OQ-26 verified PHI-stripped CEF event. |
| R-010 (vulnerable bundled component) | Med | Y | npm audit clean at v1.2.0; quarterly review scheduled. |
| R-011 (insider exfiltration via export) | Low | Y | Export disabled for `coordinator` role at Center; admin export only. |
| R-012 (power-loss DB corruption) | Low | Y | UPS on workstation; OQ-43 verified corrupt-detection. |
| R-013 (failed migration mid-way) | Low | Y | OQ rolled forward cleanly; no migrations pending. |
| R-014 (cross-org data leak) | Low | Y | Single-org deployment at Center; cross-org test suite green in vendor CI. |
| R-015 (online brute-force) | Low | Y | Account lockout verified by OQ-03. |
| R-016 (TOTP phishing) | Med | Y | Mitigated by Center's annual security awareness training. |
| R-017 (OPTN export to UNet) | Low | Y | "DO_NOT_SUBMIT" watermark verified by OQ-70. |
| R-018 (living-donor follow-ups missed) | Low | Y | 6/12/24-month tasks verified by PQ-07. |
| R-019 (FDA device misclassification) | Med | Y | Center QA confirmed `FDA_DEVICE_RATIONALE.md` reviewed by Center counsel. |

## 5. Training

Workforce training on the validated version has been completed and
recorded:

| Role | Trainees trained | Date | Trainer |
|---|---|---|---|
| Admin | 1 | 2026-06-15 | Center Validation Lead |
| Coordinator | 4 | 2026-06-16, 2026-06-17 | Center Validation Lead |
| Physician (read-only) | 2 | 2026-06-18 | Center Validation Lead |
| Auditor (read-only) | 1 | 2026-06-19 | Center Validation Lead |

Training records held in the Center's HRIS, document IDs
`NRTC-TRN-2026-{088…092}`. *(example IDs)*

## 6. Conclusion and authorization

Based on the documented evidence in this VSR and its referenced IQ / OQ /
PQ deliverables, **TransTrack v1.2.0 is authorized for production use at
Northshore Regional Transplant Center** *(fictional, demonstration)*
effective 2026-07-02 and shall be subject to the periodic review schedule
defined in `TT-VP-001 §8`.

Periodic review #1 is scheduled for **2027-07-02**, comprising:

- Audit-log integrity sample (200 rows, random sample over the year)
- Backup-restore drill (per BCDR policy)
- Access review (RBAC + MFA enrollment)
- CVE / advisory review for bundled components
- Re-execution of any OQ test cases impacted by patches applied during
  the year (delta validation per `TT-VP-001 §7`)

| Role | Name (placeholder) | Signature | Date |
|---|---|---|---|
| Validation Lead | _Sarah Chen, RN_ | _signed_ | 2026-07-01 |
| Quality Assurance Officer | _Marcus Johnson, MS_ | _signed_ | 2026-07-02 |
| Information Security Officer | _Priya Patel, CISSP_ | _signed_ | 2026-07-02 |
| Transplant Administrator | _Dr. R. Whitfield_ | _signed_ | 2026-07-02 |

---

> **End-of-document reminder:** the people, organization, and signatures
> above are demonstration data. Replace before treating this file as a
> real validation record.
